<DOC>
	<DOCNO>NCT03076515</DOCNO>
	<brief_summary>This prospective , randomize , double-blind , sham control multi-center trial . Ratio treatment control group 1:1 , stratify center use preventive medication .</brief_summary>
	<brief_title>Migraine Treatment With Nerivio Migra Neurostimulation Device</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>1 . Patient 1875 year old . 2 . Patient meeting ICHD3 diagnostic criterion migraine without aura . 3 . Patients report 28 migraine attack per month . 4 . Patient must able willing comply protocol . 5 . Patient must able willing provide write informed consent . 6 . Male nonpregnant / nonlactating female ( NOTE : Females child bear potential must negative pregnancy test ) must willing use adequate contraceptive mean study 1 . Has significant pain problem opinion investigator may confound study assessment 2 . Is currently implanted electrical and/or neurostimulator device ( e.g . cardiac pacemaker defibrillator , vagus nerve neurostimulator , deep brain stimulator , spinal stimulator , bone growth stimulator cochlear implant , Sphenopalatine ganglion stimulator Occipital nerve stimulator ) . 3 . Known uncontrolled epilepsy . 4 . Use Cannabis include medical use . 5 . Has chronic migraine ( 15 headache day per month ) . 6 . Changed usage dosage migraine preventive medication last two month 7 . Has undergone nerve block ( occipital ) head neck within last 2 week . 8 . Is participate clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>